<div class="article">
	<h3>Liposome Technology Inc.</h3>
	<div class="article-info">
		<ul>
			<li>Author: Author Unknown</li>
			<li>Date: 08/15/90</li>
		</ul>
	</div>
	<p class="article-leader">MENLO PARK, Calif. -- New York investor David Blech said
in a filing with the Securities and Exchange Commission that
he increased his stake in Liposome Technology Inc. to 35.3%
of the common shares outstanding.
   Mr. Blech said he holds 3,573,680 shares, including
123,500 shares purchased Aug. 1 at prices of $3.06 to $3.50 a
share. No reason was given for the boost.</p>
	<div class="article-body"><p>A Liposome spokesman said Mr. Blech already is the
company's largest shareholder, but was unable to confirm the
recent additions to his stake.</p>
<p></p></div>
</div>
